Children may be exposed to potentially harmful excipients through unlicensed and off-label use of adult medicines.
According to The Pharmaceutical Journal, excipient exposure should be minimised as many liquid formulations have not been studied extensively, or authorised for paediatric use. Children may not be able to metabolise or eliminate an excipient in the same way as an adult, because of their physiological and developmental differences.
To read the full article and for a full list of potential problematic excipients, click here.
SyrSpend® SF provides a safe solution for pediatrics.
SyrSpend® SF is Fagron’s innovative family of sugar-free oral suspending vehicles. These vehicles provide an excellent formulation for easy preparation of smooth, elegant oral suspensions to achieve maximum patient satisfaction and compliance. Free from harmful ingredients, SyrSpend® SF can offer solutions for treatments in pediatrics.